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ABSTRAK
Latar belakang: disfungsi tiroid lebih banyak terjadi pada pasien diabetes dibandingkan populasi umum. 
Sampai saat ini belum ada penelitian yang menemukan prevalensi hipotiroidisme dan hipertiroidisme pada 
pasien diabetes mellitus di Indonesia. Tujuan penelitian ini adalah menemukan proporsi dan karakteristik 
disfungsi tiroid pada pasien diabetes melitus tipe 2 di Indonesia. Metode: penelitian potong lintang dilakukan 
di Poliklinik Endokrin dan Diabetes Departemen Ilmu Penyakit Dalam Rumah Sakit Cipto Mangunkusumo pada 
bulan Juli hingga September 2015. Penelitian ini mengikutsertakan pasien diabetes melitus tipe 2, usia di atas 
18 tahun, dan bersedia melakukan pemeriksaan laboratorium fungsi tiroid. Dalam penelitian ini, hipotiroidisme 
didefinisikan TSH lebih dari 4,0 mIU/L, sementara hipertiroidisme didefinisikan TSH kurang dari 0,4 mIU/L 
menggunakan metode eCLIA. Hasil: dari 364 subjek yang direkrut di Poliklinik Endokrin dan Diabetes Rumah 
Sakit Cipto Mangunkusumo, sebanyak 303 subjek mengikuti penelitian hingga analisis. Dua ratus tujuh puluh 
tiga (273) (90,1%) subjek eutiroidisme, 7 (2,31%) subjek hipertiroidisme, dan 23 (7,59%) subjek hipotiroidisme. 
Sebagian besar subjek termasuk hipotiroidisme subklinis (56,5% berdasarkan Index Zulewski dan Billewicz, 
65,2% berdasarkan pemeriksaan fT4), sementara 42,9% dan 71,4% subjek termasuk kategori hipertiroidisme 
klinis masing-masing berdasarkan tampilan klinis dan pemeriksaan fT4. Kesimpulan: pada pasien diabetes 
melitus tipe 2, proporsi hipotiroidisme adalah 7.59% dan proporsi hipertiroidisme adalah 2.31% sehingga 
secara total, disfungsi tiroid memiliki proporsi sebesar 9.9%. Disarankan skrining fungsi tiroid dilakukan pada 
pasien risiko tinggi sebagai manajemen komprehensif pasien diabetes melitus tipe 2. 
Kata kunci: disfungsi tiroid, hipotiroidisme, hipertiroidisme, diabetes melitus tipe 2.
ABSTRACT
Background: thyroid dysfunction is more likely to occur in diabetes mellitus patients than general population. 
Until now, no study has been done to find prevalence of hypothyroidism and hyperthyroidism in Indonesian 
diabetics. This study aimed to find the proportion and characteristics of thyroid dysfunction in Indonesian 
type 2 diabetes mellitus patients. Methods: a cross-sectional study was conducted in Endocrine and Diabetes 
Polyclinic, Department of Internal Medicine, Cipto Mangunkusumo Hospital from July to September 2015. This 
study include type 2 diabetes mellitus patients, age ≥ 18 year-old, willing to undergo thyroid laboratory testing. 
In this study, hypothyroidism defined as TSH more than 4.0 mIU/L, while hyperthyroidism is defined as TSH 
less than 0.4 mIU/L with eCLIA. Results: from 364 subjects who were recruited from Endocrine and Diabetes 
Polyclinic, Cipto Mangunkusumo Hospital, 303 subjects underwent this study until analysis. Two hundred and 
three (273) subjects (90.1%) were euthyroid, 7 subjects (2.31%) were hyperthyroid, and 23 subjects (7.59%) were 
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hypothyroid. Majority of the patients had subclinical hypothyroidism (56.5% based on Zulewski and Billewicz 
Score and 65.2% based on fT4 laboratory result), while 42.9% and 71.4% subjects had clinical hyperthyroidism 
based on clinical appearance and fT4 laboratory result respectively. Conclusion: proportion of hypothyroidism 
was 7.59% and hyperthyroidism was 2.31%, while the proportion of total thyroid dysfunction was 9.9% among 
diabetics. It is suggested that screening for thyroid dyscfunction can be done in high risk condition as a part of 
comprehensive management in type 2 diabetes mellitus patients.
Keywords: thyroid dysfunction, hypothyroidism, hyperthyroidism, type 2 diabetes mellitus.
INTRODUCTION
Prevalence of thyroid dysfunction is greater 
in diabetes patients compared to the general 
population.1-3 Prevalence of thyroid dysfunction 
in general population is around 6.6-13.4%, 
while in diabetes population around 10-24%.1 
Studies found that subclinical hypothyroidism 
is the most common thyroid dysfunction in 
diabetic population. Study from Pasupathi et 
al4 found that the prevalence of hypothyroidism 
and hyperthyroidism in diabetes patients reach 
28% and 17%, respectively. Studies and several 
organizations recommend thyroid screening test 
for diabetic patients.
Connection between thyroid dysfunction 
especially hypothyroidism and type-1 diabetes 
mellitus is well-etablished since the autoimmune 
mechanism in type-1 diabetes correlates with 
thyroid autoimmunity.5,6 Meanwhile, explanation 
of the correlation between type 2 diabetes and 
thyroid dysfunction is unclear as the mechanism 
is very complex and involves many variables 
such as synthesis of thyrotropin releasing 
hormone (TRH), circadian rhythm of thyroid 
stimulating hormone (TSH), insulin resistance, 
autoimmunity, and the use of metformin.7,8 The 
co-existence of thyroid dysfunction in type 
2 diabetes mellitus patients will worsen the 
macrovascular and microvascular complications, 
morbidity, mortality, and quality of life.7 
Detecting thyroid dysfunction in type 2 diabetes 
patients will inform clinicians to give optimal 
treatment for metabolic conditions since thyroid 
condition such as hypothyroidism will delicate 
achievement of glycemic target and other 
comorbidities.9
Although thyroid dysfunction in diabetic 
population had been studied by many researchers 
around the world, until recently, there is no 
study about thyroid dysfunction in type-2 
diabetes mellitus patients in Indonesia. The 
aim of this study was to find the proportion 
and characteristics of thyroid dysfunction in 
Indonesian type 2 diabetes mellitus patients. 
Hopefully the study will complete the database 
of thyroid dysfunction in different populations 
around the world.
METHODS
A cross-sectional study was conducted in 
Endocrine and Diabetes Polyclinic, Department 
of Internal Medicine, Cipto Mangunkusumo 
Hospital from July to September 2015. The 
inclusion criterias of the subjects were type-2 
diabetes mellitus patients, aged ≥18 years old 
and willing to undergo thyroid laboratory testing. 
Exclusion criterias were pregnant women, on 
anthyroid or thyroid hormone medication, on 
medication which impaired thyroid function, 
history of neck radiation, thyroidectomy, and 
known history of thyroid disorders (e.g. Graves’ 
disease or goiter) previously.
Study subjects were obtained from the 
polyclinic through consecutive sampling method 
with a minimum study subjects calculated 
using previous study by prevalence 24% (using 
prevalence from Devi MA et al10 study which 
has the closest similarity with our study), α 5% 
(Zα 1.96), precision (d) 10%. Based on that 
calculation, we got 292 subjects as minimum 
samples for our study. Type-2 diabetes mellitus 
patients from polyclinic were screened for 
inclusion and exclusion criterias. If suitable for 
becoming our study subjects, patients were asked 
for informed consent before undergo study. Study 
subjects must fill all test starting with history 
taking, physical examination, thyroid laboratory 
testing, and thyroid ultrasound if needed. 
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Clinical and Laboratory Parameters
In this study, hypothyroidism was defined as 
TSH more than 4.0 mIU/L detected using eCLIA 
(electro-chemiluminescence immunoassay) 
method from Cobas 6000 (Roche Diagnostics). 
Hypothyroidism was classified based on clinical 
signs and symptoms according to Zulewski 
and Billewicz Index as clinical and subclinical 
hypothyroidism, and based on free-T4 (fT4) 
laboratory result as clinical hypothyroidism 
(fT4 <0.93 µg/L) and subclinical (mild) 
hypothyroidism (normal fT4). Hyperthyroidism 
was defined as TSH less than 0.4 mIU/L with 
eCLIA. Further, hyperthyroidism was classified 
based on free-T4 (fT4) laboratory result as 
clinical hyperthyroidism (fT4 > 1.7 µg/L) and 
subclinical (mild) hyperthyroidism (normal fT4).
Statistical Analysis
Data editing was done before entering data 
to Microsoft Excell 2013 and SPSS Statistics 
17.0. Descriptive data analysis was done to 
obtain proportion and characteristics of thyroid 
dysfunction in type 2 diabetes mellitus patients.
Ethical Clearance
This study had been ethically approved by 
Research Ethic Committee from Faculty of 
Medicine Universitas Indonesia (715/UN2.F1/
ETIK/2015).
RESULTS
A total of 364 subjects were recruited from 
Endocrine and Diabetes Polyclinic, Department 
of Internal Medicine, Cipto Mangunkusumo 
Hospital. Out of those subjects, 51 subjects were 
excluded since they did not undergo thyroid 
function test procedure and 10 subjects were 
excluded because 6 subjects were actually type 
1 diabetes mellitus patients after in-depth history 
taking and 4 subjects had goiter before being 
diagnosed with type-2 diabetes mellitus. Later, 4 
subjects were excluded because 3 subjects were 
in anti-thyroid medication and 1 subjects was in 
levothyroxine therapy. At the end, 299 subjects 
were included for univariate analysis. Figure 1 
shows subject’s profile.
Type 2 diabetes mellitus paents visited Endocrine and
Diabetes Polyclinic Cipto Mangunkusumo Hospital
Recruitment from willingness to parcipate the study
364 subjects candidate
303 subjects were calculated for study
prevalence (proporon)
10 subjects were excluded
because 6 subjects actually type 1
diabetes mellitus paents and 4
subjects have goiter before being
diagnosed with diabetes
51 subjects were
excluded since they did
not undergo thyroid
laboratory examinaon
299 subjects were calculated for TSH
examinaon and univariate analysis
4 subjects were excluded for
because 3 subjects use an-
thyroid drugs and 1 subject uses
levothyroxin
Figure 1. Flowchart of study subject recruitment
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Table 1. Socio-demography and clinical characteristics of the study subjects (n=299)
Characteristics Category Frequency (n, %)
Gender Male 128 (42.8%)
Female 171 (57.2%)
Age, Median (Range; year) 60 (37-86)
Education background Uneducated 2 (0.7%)
Elementary school 56 (18.7%)
Junior high school 39 (13%)
Senior high school 108 (36.1%)
Academy 35 (11.7%)
Bachelor 59 (19.7%)




Government sector 12 (4%)
Private sector 29 (9.6%)
Profesional 14 (4.6%)
Diabetes duration 1-5 years 109 (36.5%)
5-10 years 62 (20.7%)
> 10 years 128 (42.8%)
Median (Range; year) 10 (1-45)
Diabetes therapy Dietary 1 (0.3%)
Oral anti-diabetes 145 (48.4%)
Insulin 62 (20.7%)
Combination (oral and insulin) 91 (30.4%)
Body mass index (BMI) < 18,5 Kg/m2 (underweight) 10 (3.3%)
18,5-22,9 Kg/m2 (normoweight) 82 (27.4%)
23-24,9 Kg/m2 (overweight) 68 (22.7%)
25-30 Kg/m2 (grade 1 obesity) 97 (32.4%)
> 30 Kg/m2 (grade 2 obesity) 42 (14%)
Median (Range; Kg/m2) 24.7 (16.7-37.2)
Diabetes complication Cerebrovascular disease 31 (10.4%)
Coronary artery disease 68 (22.7%)
Diabetic nephropathy 169 (56.5%)
Diabetic retinopathy 68 (22.7%)
Diabetic neuropathy 147 (49.2%)
Peripheral arterial disease 11 (3.7%)
Diabetic foot 53 (17.7%)
Clinical manifestation of thyroid 
dysfunction (based on Billewicz and 
Zulewski Index)
No clinical manifestation of thyroid dysfunction 78 (26.1%)
Query clinical manifestation of thyroid dysfunction 190 (63.5%)
Positive clinical manifestation of thyroid dysfunction 31 (10.4%)
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Based on thyroid status, 273 subjects 
(90.1%) were euthyroid, 7 subjects (2.31%) 
were hyperthyroid, and 23 subjects (7.59%) 
were hypothyroid. In total, 30 subjects (9.9%) 
have thyroid dysfunction in this study. Table 
2 and Table 3 show the classification of 
hypothyroidism and hyperthyroidism based on 
clinical appearance and fT4 laboratory result.
Hypothyroid patients were classified to 
clinical and subclinical hypothyroidism based 
on clinical appearance using Zulewski and 
Billewicz Score and based on laboratory result 
(fT4). According to these two methods, majority 
of the patients had subclinical hypothyroidism 
(56.5% based on Zulewski and Billewicz Score 
and 65.2% based on fT4 laboratory result), 
while 42.9% and 71.4% subjects were clinical 
hyperthyroidism based on clinical appearance 
and fT4 laboratory result.
DISCUSSION
Prevalence of thyroid dysfunction in type 2 
diabetes mellitus patients become an attention 
in epidemiological studies in the field of 
endocrinology in the last decade.7,11 Several 
studies with various design and aim were held to 
find out prevalence and determinants of thyroid 
dysfunction in type-2 diabetes patients.11,12 
The focus of these studies were prevalence of 
hypothyroidism which has connection with 
pathophysiology, pathogenesis, comorbidities, 
and complications of type-2 diabetes mellitus.12,13
This  s tudy obtained proport ion of 
hypothyroidism and hyperthyroidism in type-2 
diabetes population. About 23 subjects (7.59%) 
have hypothyroidism and 7 subjects (2.3%) 
have hyperthyroidism. Proportion of thyroid 
dysfunction in this cross-sectional – Indonesian 
population was 9.9%. Further, it was paradoxically 
seen that subclinical hypothyroidism was higher 
than clinical hypothyroidism (based on clinical 
presentation and laboratory result), but clinical 
hyperthyroidism was more than twice number 
of subclinical hyperthyroidism.
Other interesting finding was that the clinical 
appearance of hypothyroidism was more lucid 
in diabetic patients since the proportion based 
on clinical appearance score (e.g. Zulewski and 
Billewicz Index) for clinical hypothyroidism 
more higher than the proportion obtained by 
actual laboratory result (43.5% versus 34.8%). 
This condition can be caused by overlapping 
clinical condition between hypothyroidism and 
diabetes.7 Contrariwise, in hyperthyroid subjects, 
the proportion of clinical hyperthyroidism was 
higher based on laboratory result than based 
on clinical apperance, although we did not 
calculate the Wayne’s Index clinical score for 
hyperthyroidism. Based upon retrospective 
history taking (i.e. sign and symptom in the 
past), 3 subjects who use anti-thyroid drug 
had experienced toxic thyroid condition but 
remained non-toxic after the use of anti-thyroid 
drug. Again, this condition may be related to 
diabetes which can mask signs and symptoms 
of thyrotoxicosis. It is known that uncontrolled 
diabetes can influence assessment of thyroid 
toxic condition by falsely decreasing the blood 
Table 2. Classification of hypothyroidism in diabetes subjects (n=23)
Methods Diagnosis Frequency (n, %)
Zulewski Index Score > 5 or  









Table 3. Classification of hypothyroidism in diabetes subjects (n=23)
Methods Diagnosis Frequency (n, %)
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levels of thyroxine and triiodothyronine.14
The proportion of hypothyroidism in type 2 
diabetes mellitus patients was 7.59% which was 
lower than previous studies in other populations. 
(Table 4 shows resume of the studies on thyroid 
dysfunction in diabetes patients from different 
populations around the world). Based on the meta-
analysis which held by Han C et al.11, the prevalence 
of subclinical hypothyroidism (pooled adjusted) in 
type-2 diabetes mellitus patients was 10.2%. This 
number was obtained from 36 studies with the 
range of prevalence between 4.69% to 18.86%. 
Type-2 diabetes mellitus population which has the 
highest prevalence of subclinical hypothyroidism 
was Indian population who had prevalence above 
20%. Studies done by Vikhe VB et al.,15 Singh G 
et al.,16 Devi MA et al.,10 Demitrost L et al.,17 and 
Uppal V et al.18 obtained prevalence of subclinical 
hypothyroidism of 22%, 23.75%, 24%, 27.7%, 
and 17%, respectively. These five studies done in 
Indian population showed how big the burden of 
hypothyroidism in type 2 diabetes patients in India.
Han C11 meta-analysis collected studies from 
Chinese population. Studies done by Liu W et 
al., Zhang NY et al., Deng X et al., Zang SF 
et al., Zhang MY et al., and Shi YS et al., that 
mentioned six studies held in 2007-2012, had a 
prevalence of subclinical hypothyroidism in type 
2 diabetes mellitus of 10.85%, 12.02%, 12.81%, 
12.31%, 12.5%, and 9.69%.11 Compared to Indian 
and Chinese population, Indonesian population 
had lower proportion of hypothyroidism among 
diabetics. It can be caused by the high prevalence 
of iodine deficiency in China and India compared 
to Indonesian population.19,20
Explanation of variability in hypothyroidism 
prevalence in different diabetes populations can 
be made by several parameters such as adequacy 
of iodine intake which can affect the baseline 
thyroid status of population and presence of 
goiter, metabolic determinants like population 
glycemic achievement, metabolic syndrome, 
several comorbidities which related to thyroid 
dysfunction, and in epidemiology perspective, 
the total prevalence of diabetes in the population. 
In other words, studies about comorbidities of 
diabetes and thyroid dysfunction is population 
specific. Therefore, although it has been studied 
many times in other populations, data from 
Indonesian population is still highly needed. 
In fact, this is the first study about thyroid 
dysfunction in Indonesian diabetics population.
While  hypothyroidism has several 
mechanisms related to type-2 diabetes mellitus, 
the presence of hyperthyroidism can be back 
and forth since the established basic mechanism 
was the hypermetabolism in hyperthyroidism, 
affecting glucose intolerance (referring to 
impaired glucose tolerance or type 2 diabetes 
mellitus),21,22 not contrariwise. It is also known 
that hyperthyroidism induces glucose intolerance 
by lowering both insulin secretion and peripheral 
insulin sensitivity.23 On the other hand, there is 
also a hypothesis that both hyperthyroidism and 
diabetes are immune-related disorders which 
can be cross-linked and happen in the same 
individual. Whatsoever the mechanism and time-
temporality, this two conditions must be treated 
separately with their own target respectively.
This study collected patients from tertiary 
hospital who received the state of the art 
treatment with many resources. They are treated 
ideally by endocrinology consultants, fellow 
endocrinologists, and internal medicine residents 
rotating in endocrinology division. This condition 
made the characteristics of the patients quite 
different from general population. It assumed that 
the prevalence of thyroid dysfunction was higher 
in general population who do not achieve diabetes 
treatment, education, and awareness like our study 
subjects got in Cipto Mangunkusumo Hospital.
Our study was set in a hospital-based 
population (i.e. outpatient polyclinic) which 
can be different from other community studies 
on thyroid disorders done in the past, such as 
Colorado Thyroid Disease Study,24 Whickham 
Study,25 and NHANES III26 which was done 
nationally in the United States. In Indonesia, 
community survey in thyroidology field is still 
sparse except studies about iodine deficiency.27 
Similar to our study, many studies about thyroid 
dysfunction in type-2 diabetes mellitus patients 
was hospital-based studies.11 The implication 
was that generalization of the studies can be 
made to patients in clinical practice setting, not 
in the community. Therefore, thyroid dysfunction 
screening was only recommended in patients 
attending healthcare facilities.
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Table 4. The summary of studies on thyroid dysfunction in type 2 diabetes mellitus patients
Study Population Prevalence and proportion
Palma CCSSV 
et al.1
Cross-sectional study of 386 type 1 and type 2 diabetes 
mellitus patients, adult (Brazil).
Thyroid dysfunction 14.7%.
Subclinical hypothyroidism 13% (type 1 
diabetes) and 12% (type 2 diabetes).
Pasupathi P  
et al.4
Comparative cross-sectional study of 100 diabetic patients 
and 100 non-diabetic patients, adult (India).
Thyroid dysfunction 45% 
(hypothyroidism 28%, hyperthyroidism 
17%).
Manjunath SC  
et al.28
Cross-sectional study of 100 type 2 diabetes mellitus 
patients, adult (India).
Subclinical hypothyroidism 13%.
Vikhe VB et al.15 Comparative cross-sectional study of 50 diabetic patients 
and 50 non-diabetic patients, adult (India).
Hypothyroidism 8%, subclinical 
hypothyroidism 14%.
Singh G et al.16 Comparative cross-sectional study of 80 diabetic patients 
and 80 non-diabetic patients, adult (India).




Comparative cross-sectional study of 908 diabetic patients 
and 304 non-diabetic patients, adult (Yordania).
Thyroid dysfunction 12.5% (subclinical 
hypothyroidism 4.1%).
Gopinath B  
et al.30
Cohort of 113 type 2 diabetes patients and 950 non-diabetic 
subjects, age > 49 year-old (Australia).
Subclinical hypothyroidism 3.5%, overt 
hypothyroidism 1.8%.
Devi MA et al.10 Comparative cross-sectional study of 80 type 2 diabetes 
mellitus patients and 80 healthy subjects (India).
Clinical and subclinical hypothyroidism 
24%.
Islam S et al.31 Comparative cross-sectional study of 50 type 2 diabetes 
mellitus patients and 50 healthy subjects (Bangladesh).
Serum fT3 of diabetes subjects were 
lower compared to control group
Kameda H et al.32 Cross-sectional study of 106 type 2 diabetes mellitus 
patients, adult (Japan).
Subclinical hypothyroidism 15%.





Comparative cross-sectional study of 147 prediabetes 
patients and 150 healthy subjects, adult (Egypt).
Subclinical hypothyroidism 16.3%.
Demitrost L  
et al.17
Cross-sectional study of 202 type 2 diabetes mellitus 
patients, adult (India).
Overt hypothyroidism 11.4%, 
subclinical hypothyroidism 16.3%.
Al-Geffari M  
et al.35
Cross-sectional study of 411 type 2 diabetes mellitus 
patients, adult (Saudi Arabian).
Hypothyroidism 15.3%, subclinical 
hypothyroidism 9.5%, overt 
hypothyroidism 0.5%.
Alam MJ et al.36 Comparative cross-sectional study of 104 type 2 
diabetes mellitus patients and 104 healthy subjects, adult 
(Bangladesh).
Hypothyroidism 18.6%.
Shashi A et al.37 Comparative cross-sectional study of 117 type 2 diabetes 
mellitus & hypothyroid patients and 100 healthy subjects, 
age 20-50 year-old (India). 
Guney E et al.38 Cross-sectional study of 802 diabetes mellitus patients, 
adult (Turky).
Hypothyroidism 1.1%.
Diez JJ et al.39 Cross-sectional study of 828 type 2 diabetes mellitus 
patients, age > 60 year-old (Spain).
Distiller LA et al.40 Cross-sectional study of 918 type 2 diabetes mellitus 
patients, adult (South Africa).
Hypothyroidism 11.8%.
Chubb SAP  
et al.41
Prospective cohort of 420 type 2 diabetes mellitus patients, 
women (Fremantle Diabetes Study, Australia).
Subclinical hypothyroidism 8.6%.
Akbar DH et al.42 Comparative cross-sectional study of 100 type 2 diabetes 
mellitus patients and 100 healthy subjects, adult (Saudi 
Arabian).
Subclinical hypothyroidism 23%, 
hypothyroidism 15.3% (LADA group), 
subclinical hypothyroidism 4%, 
hypothyroidism 2.72% (type 2 diabetes 
group).
Diez JJ et al.43 Comparative cross-sectional study of 1112 type 2 diabetes 
mellitus patients and 911 healthy subjects, adult (Spain).
Overt hypothyroidism 9.9%, subclinical 
hypothyroidism 8.5%.
Fournier JP  
et al.44
Prospective cohort of 5689 diabetes patients & hypothyroid 
and 59937 diabetes patients (UK).
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Table 4. The summary of studies on thyroid dysfunction in type 2 diabetes mellitus patients
Study Population Prevalence and proportion
Chen HS et al.45 Cross-sectional study of 588 type 2 diabetes mellitus 
patients, adult (Taiwan).
Overt hypothyroidism 3.1%, 
hypothyroidism 0.9%, dan subclinical 
hypothyroidism 6.3%.
Yasuda T et al.46 Cross-sectional study of 159 type 2 diabetes mellitus 
patients, adult (Japan).
Subclinical hypothyroidism 17%.
Furukawa S  
et al.47





Prospective cohort of 472 type 2 diabetes & hypothyroid 
patients and 472 type 2 diabetes & euthyroid, adult (UK).
Uppal V et al.18 Case control study of 120 type 2 diabetes mellitus patients 
and 117 healthy subjects, adult (India).
hypothyroidism 17%.
Lambadiari V  
et al.49
Quasi-experimental, 17 healthy subjects, 22 offspring of 
diabetes patients, 15 impaired glucose tolerance subjects, 
and 24 type 2 diabetes mellitus patients.
Ghazali SM  
et al.50
Comparative cross-sectional study of 64 type 2 diabetes 
mellitus patients and 36 healthy subjects, adult (Nigeria).




Cross-sectional study of 563 diabetes mellitus patients, 
adult (South Africa).
Subclinical hypothyroidism 0.9% from 
total diabetes patients, subclinical 
hypothyroidism 1.6% from type 2 
diabetes patients.
Kashi Z et al.52 Comparative cross-sectional study of 103 type 2 diabetes 
mellitus patients and 103 healthy subjects, adult (Iran).
Hypothyroidism 17.5%.





Comparative cross-sectional study of 1848 type 2 diabetes 
mellitus patients and 3313 healthy subjects, adult (Mexico).
Hypothyroidism 5.7%.
Swamy RM  
et al.55
Cross-sectional study of 58 type 2 diabetes mellitus 
patients, adult (India).
Hypothyroidism 12.06%, subclinical 
hypothyroidism 31.03%.
Al-Shibani et al.56 Cross-sectional study of 415 diabetes mellitus patients, 
adult (Iraq).
Hypothyroidism 4.1%, subclinical 
hypothyroidism 6.8%.
CONCLUSION
This study revealed a quite high proportion 
of thyroid dysfunction in type 2 diabetes mellitus 
patients attending Endocrine and Diabetes 
Outpatient Poyclinic in Cipto Mangunkusumo 
Hospital. The proportion of hypothyroidism was 
7.59% and hyperthyroidism was 2.31% with 
total thyroid dysfunction proportion of 9.9%. 
According to recommendation from several 
endocrinology and thyroidology organizations, 
TSH screening should be done first in patients 
attending healthcare facilities, not as mass 
screening in the community. It was suggested 
that screening for thyroid dyscfunction can be 
selectively done in high risk condition as a part of 
comprehensive management in type-2 diabetes 
mellitus patients.
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